Bioextrax AB (publ) (STO:BIOEX)
Sweden · Delayed Price · Currency is SEK 2.540
-0.110 (-4.15%)
Jul 17, 2026, 4:39 PM CET
Bioextrax AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.35 | 1.31 | 1.01 | 3.01 | 2.23 | 1.03 | |
Revenue Growth (YoY) | 126.60% | 29.48% | -66.40% | 34.81% | 116.07% | 349.97% |
Cost of Revenue | 1.16 | 1.26 | 1.43 | 1.34 | 1.35 | 1.03 |
Gross Profit | 0.19 | 0.05 | -0.42 | 1.67 | 0.89 | 0 |
Selling, General & Admin | 17.31 | 16.74 | 16.04 | 22.37 | 19.19 | 10.18 |
Depreciation & Amortization Expenses | 1.1 | 1.13 | 1.16 | 0.86 | 0.48 | 0.35 |
Other Operating Expenses | 0.01 | 0.02 | -0.08 | 0.04 | -0.12 | 0 |
Total Operating Expenses | 18.41 | 17.89 | 17.12 | 23.27 | 19.55 | 10.53 |
Operating Income | -18.18 | -17.84 | -17.54 | -21.6 | -18.67 | -10.53 |
Interest Income | 0.13 | 0.14 | 0.2 | 0.09 | 0 | 0 |
Interest Expense | -0 | -0 | -0 | 0 | 0 | -0 |
Total Non-Operating Income (Expense) | 0.13 | 0.13 | 0.2 | 0.09 | 0 | -0 |
Pretax Income | -18.05 | -17.71 | -17.34 | -21.51 | -18.67 | -10.53 |
Net Income | -18.05 | -17.71 | -17.34 | -21.51 | -18.67 | -10.53 |
Net Income to Common | -18.05 | -17.71 | -17.34 | -21.51 | -18.67 | -10.53 |
Shares Outstanding (Basic) | 41 | 40 | 33 | 27 | 17 | 13 |
Shares Outstanding (Diluted) | 41 | 40 | 33 | 27 | 17 | 13 |
Shares Change (YoY) | 15.33% | 18.85% | 25.69% | 56.93% | 26.08% | -10.98% |
EPS (Basic) | -0.44 | -0.45 | -0.52 | -0.81 | -1.10 | -0.79 |
EPS (Diluted) | -0.44 | -0.45 | -0.52 | -0.81 | -1.10 | -0.79 |
Free Cash Flow | -13.24 | -26.2 | -18.99 | -24.41 | -24.38 | -9.45 |
Free Cash Flow Per Share | -0.32 | -0.66 | -0.57 | -0.92 | -1.44 | -0.71 |
Gross Margin | 14.12% | 3.90% | -41.44% | 55.53% | 39.74% | 0.00% |
Operating Margin | -1350.59% | -1362.80% | -1734.82% | -717.81% | -836.34% | -1019.26% |
Profit Margin | -1340.79% | -1352.56% | -1714.94% | -714.76% | -836.34% | -1019.55% |
FCF Margin | -983.51% | -2001.38% | -1878.64% | -811.23% | -1092.29% | -915.00% |
EBITDA | -17.08 | -16.71 | -16.38 | -20.74 | -18.19 | -10.18 |
EBITDA Margin | -1269.24% | -1276.78% | -1620.18% | -689.20% | -814.96% | -985.38% |
EBIT | -18.18 | -17.84 | -17.54 | -21.6 | -18.67 | -10.53 |
EBIT Margin | -1350.59% | -1362.80% | -1734.82% | -717.81% | -836.34% | -1019.26% |